What’s New!

NEWS

When Large-Language-Models Make Sense: A Game Changer for Enterprises

At EDBI’s inaugural masterclass in collaboration with NVIDIA, we delved into the world of Large Language Models (LLM) and glimpsed into the opportunities and challenges in its landscape led by Dr. Ettikan K Karuppiah, director and technologist and Dr. Deb Goswani, head of developer programs - big data and analytics at NVIDIA.
A recipe for success: How to thrive in Southeast Asia alternative protein market
Singapore has taken bold steps in accelerating innovation in the agrifood landscape in the recent years. For instance, while global regulators grappled with how to regulate cell-based foods, Singapore Food Agency (SFA) broke the impasse by becoming the first to grant regulatory approval for cell-based meat in 2021.
Ambiq Achieves Milestone of Powering Over 200 Million IoT Devices
Austin, TX and Singapore, 13 June 2023 – Ambiq®, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in energy efficiency, achieved a key milestone of powering over 200 million IOT devices earlier this year.

DocuSign Ranks #3 on Forbes World’s Best 100 Cloud Companies List

DocuSign Has Emerged as the Leader of One of the Fastest Growing Categories in the Cloud Today: Digital Transaction Management

Sprinklr Announces Integration with LINE Business Connect

Global brands can now publish content to LINE Business Connect, the API platform for Japan’s Largest Global Messenger and Smartphone Portal, LINE

LogRhythm Closes USD50 Million Financing to Extend Global Leadership in Security Intelligence and Analytics

SINGAPORE —August 30, 2016 — LogRhythm, The Security Intelligence Company, today announced that it has closed a $50 million round of new financing.

Paxata Accelerates Asia-First Strategy, Forms Strategic Partnership With K.K. Ashisuto Japan

REDWOOD CITY, Calif., Aug. 29, 2016 (GLOBE NEWSWIRE) -- Paxata, provider of the only enterprise-grade self-service data preparation platform, today announced it has formed a strategic partnership with K.K. Ashisuto where they will serve as the master distributor of Paxata in the Japanese market.

RetailNext Drives Retail IoT Market Expansion in APAC Region with Singapore Investments

Strategic Growth Investment from EDBI and Expanded Singapore Office Drive Asia-Pacific Regional Growth

DocuSign Doubles Down in Real Estate

SAN FRANCISCO, July 25, 2016 /PRNewswire/ -- DocuSign today announced that the company has deepened its investment in the real estate market. As part of this broader commitment, DocuSign will debut new partnerships, expand several existing partnerships, announce additional Real Estate thought leaders to its Advisory Board, and launch significant new product enhancements during Inman Connect 2016 in San Francisco August 2-5, 2016.

Sprinklr Raises USD105 Million at USD1.8 Billion Valuation to Help Enterprises Unify Their Front Office

NEW YORK -- JULY 20, 2016 -- Sprinklr, the world’s most complete enterprise social technology company, today announced $105 million in new funding at a $1.8 billion valuation. The round, which brings the company’s total funding to $239 million, was led by Temasek, a large, Singapore-based investment firm focused on long-term value creation

Singapore VC: Get smart

Singapore’s smart nation urban development policy has attracted noticeable interest from the VC industry. The plan’s broad inclusiveness and lack of hard targets could bode well for its sustainability

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

SINGAPORE, July 7, 2016 /PRNewswire/ -- QT Vascular Ltd., together with its subsidiaries (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announced today it has received CE mark clearance for the sale and distribution of the Chocolate Heart™ drug-coated PTCA balloon for dilatation of the stenotic portion of coronary arteries for the purpose of improving myocardial perfusion in Europe.

QT Vascular Receives FDA 510(K) Clearance for CHOCOLATE XD™, A Novel PTCA Balloon

SINGAPORE, 27 June 2016 – QT Vascular Ltd., together with its subsidiaries (the “Company” or “QT Vascular”, and together with its subsidiaries, the “Group”), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announced today it has received 510(k) clearance from the US Food and Drug Administration (“FDA”) for the sale and distribution of the Chocolate XD™ PTCA catheter for balloon dilatation of the stenotic portion of coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion including in-stent restenosis.